Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5‐azacytidine

The compound 5‐azacytidine has been previously shown to convert cells of the rat embryonic fibroblastic cell line, C3H/10T1/2, into myoblasts, adipocytes, and chondrocytes. Rare, resident cells of bone marrow and periosteum, referred to as mesenchymal stem cells, have been shown to differentiate into a number of mesenchymal phenotypes including bone, cartilage, and adipocytes. Rat bone marrow‐derived mesenchymal stem cells were exposed to 5‐azacytidine beginning 24 h after seeding twice‐passaged cells into culture dishes. After an exposure of 24 h, long, multinucleated myotubes were observed in some of the dishes 7–11 days later. Cells containing Sudan black‐positive droplets in their cytoplasm were also observed. Thus, culture‐propagated rat bone marrow mesenchymal stem cells appear to have the capacity to be induced to differentiate in vitro into myogenic and adipocytic phenotypes, although nonmesenchymal cells (rat brain fibroblasts) cannot be so induced. Taken together, these observations provide support for the suggestion that mesenchymal stem cells in the bone marrow of postnatal organisms may provide a source for myoprogenitor cells which could function in clinically relevant myogenic regeneration. © 1995 John Wiley & Sons, Inc.

[1]  Arnold I. Caplan,et al.  Mesenchymal Stem Cells , 1991, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[2]  S. Bruder,et al.  In vitro differentiation of bone and hypertrophic cartilage from periosteal-derived cells. , 1991, Experimental cell research.

[3]  S. Kaufman,et al.  In vitro development of precursor cells in the myogenic lineage. , 1991, Developmental biology.

[4]  V. Goldberg,et al.  Culture‐expanded human periosteal‐derived cells exhibit osteochondral potential in vivo , 1991, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[5]  J. Triffitt,et al.  Adipocytic cells cultured from marrow have osteogenic potential. , 1991, Journal of cell science.

[6]  D. Gazit,et al.  Osteochondral differentiation and the emergence of stage-specific osteogenic cell-surface molecules by bone marrow cells in diffusion chambers. , 1990, Bone and mineral.

[7]  S. Wientroub,et al.  Bone marrow‐derived stromal cell line expressing osteoblastic phenotype in vitro and osteogenic capacity in vivo , 1989, Journal of cellular physiology.

[8]  J. Aubin,et al.  Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: effect of dexamethasone , 1988, The Journal of cell biology.

[9]  Harold Weintraub,et al.  Transfection of a DNA locus that mediates the conversion of 10T1 2 fibroblasts to myoblasts , 1986, Cell.

[10]  B. Swalla,et al.  The independence of myogenesis and chondrogenesis in micromass cultures of chick wing buds. , 1986, Developmental biology.

[11]  S. F. Konieczny,et al.  5-azacytidine induction of stable mesodermal stem cell lineages from 10T1/2 cells: Evidence for regulatory genes controlling determination , 1984, Cell.

[12]  Peter A. Jones,et al.  Changes in phenotypic expression in embryonic and adult cells treated with 5‐azacytidine , 1982, Journal of cellular physiology.

[13]  D. A. Ede,et al.  Immunohistochemical localization of cyclic AMP during normal and abnormal chick and mouse limb development. , 1981, Teratology.

[14]  R. Reiter,et al.  Stage- and position-related changes in chondrogenic response of chick embryonic wing mesenchyme to treatment with dibutyryl cyclic AMP. , 1981, Developmental biology.

[15]  C. R. Howlett,et al.  Formation of bone and cartilage by marrow stromal cells in diffusion chambers in vivo. , 1980, Clinical orthopaedics and related research.

[16]  Peter A. Jones,et al.  Multiple new phenotypes induced in 10T 1 2 and 3T3 cells treated with 5-azacytidine , 1979, Cell.

[17]  P. Jones,et al.  Phenotypic conversion of cultured mouse embryo cells by aza pyrimidine nucleosides. , 1978, Developmental biology.

[18]  P. Jones,et al.  Functional striated muscle cells from non-myoblast precursors following 5-azacytidine treatment , 1977, Nature.

[19]  S. Hauschka.  Clonal analysis of vertebrate myogenesis. 3. Developmental changes in the muscle-colony-forming cells of the human fetal limb. , 1974, Developmental biology.

[20]  S. Hauschka,et al.  Muscle development in vitro. A new conditioned medium effect on colony differentiation. , 1971, Experimental cell research.

[21]  J. Abbott,et al.  THE LOSS OF PHENOTYPIC TRAITS BY DIFFERENTIATED CELLS , 1969, The Journal of experimental medicine.

[22]  A. Friedenstein,et al.  Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. , 1968, Transplantation.

[23]  I. Konigsberg.  Clonal Analysis of Myogenesis: Its relevance to the general problem of the stability of cell-type in cultured animal cells is discussed , 1963 .

[24]  F. Stockdale,et al.  DNA synthesis and myogenesis. , 1961, Experimental cell research.

[25]  A. Caplan,et al.  Porous ceramic vehicles for rat-marrow-derived (Rattus norvegicus) osteogenic cell delivery: effects of pre-treatment with fibronectin or laminin. , 1993, The Journal of oral implantology.

[26]  A I Caplan,et al.  Characterization of cells with osteogenic potential from human marrow. , 1992, Bone.

[27]  A I Caplan,et al.  The osteogenic potential of culture-expanded rat marrow mesenchymal cells assayed in vivo in calcium phosphate ceramic blocks. , 1991, Clinical orthopaedics and related research.